Effect of Oxytocin on Emotion Recognition and Acute Psychosocial Stress in Patients with Central Diabetes Insipidus (Vasopressin Deficiency) and Healthy Controls
Descrizione riassuntiva dello studio
Patients with central diabetes insipidus suffer from a deficiency of the anti-diuretic hormone vasopressin. Patients with such a vasopressin deficiency produce a large amount of urine and must compensate for this fluid loss with a high fluid intake. Desmopressin, a medication similar to vasopressin, can be used to treat this condition. Despite treatment with desmopressin, patients often report symptoms such as general anxiety, social withdrawal, depressed mood, and have a reduced quality of life. A recent study has shown that these patients not only lack the hormone vasopressin but also the hormone oxytocin. In the brain, oxytocin is produced in the same area as vasopressin and released from the pituitary gland. The hormone is involved in important positive psychosocial aspects such as building trust, closeness, and love, has anxiolytic effects, positively influences sensations such as relaxation, and increases empathy; thus, this hormone is also referred to as the love and cuddle hormone. The observed psychological changes in patients may therefore be partially explained by this additional deficiency of oxytocin. In this study, we investigate whether a single administration of the study drug oxytocin in patients leads to an improvement in emotion perception or reduced stress reaction to psychological stress.
(BASEC)
Intervento studiato
This study is a so-called crossover study, meaning that all participants in the study receive a placebo on two study days and oxytocin as a nasal spray on two study days. After the preliminary examination, a total of four study days take place: • On two of these study days, a computer test for emotion perception is conducted – once with placebo and once with oxytocin as a nasal spray. • On the other two study days, a test of the stress reaction is conducted – once with placebo and once with oxytocin as a nasal spray.
(BASEC)
Malattie studiate
Patients with central diabetes insipidus (Arginine Vasopressin deficiency)
(BASEC)
Inclusion criteria for healthy controls 1. Healthy volunteers 2. Same age, gender, BMI, and estrogen replacement/menopause/hormonal contraceptives as the patients. 3. No medications, except hormonal contraception. Inclusion criteria for patients 1. Adult patients with a confirmed diagnosis of AVP deficiency based on recognized criteria. 2. Stable hormone replacement therapy for at least three months. (BASEC)
Criteri di esclusione
Exclusion criteria 3. Participation in a study with investigational products within the last 30 days 4. Active substance use disorder within the last six months 5. Consumption of alcoholic beverages >15 drinks/week 6. Current or past psychotic disorder (e.g., schizophrenia spectrum disorder) 7. Pregnancy and breastfeeding within the last eight weeks (BASEC)
Luogo dello studio
Basilea
(BASEC)
Sponsor
Mirjam Christ-Crain
(BASEC)
Contatto per ulteriori informazioni sullo studio
Persona di contatto in Svizzera
Mirjam Christ-Crain
061 265 25 25
mirjam.christ-crain@clutterusb.chUniversity Hospital Basel
(BASEC)
Informazioni scientifiche
non disponibile
Nome del comitato etico approvante (per studi multicentrici solo il comitato principale)
Commissione d'etica svizzera nord-ovest/centrale EKNZ
(BASEC)
Data di approvazione del comitato etico
03.09.2024
(BASEC)
ID di studio ICTRP
non disponibile
Titolo ufficiale (approvato dal comitato etico)
Effect of lntranasal Oxytocin on Emotion Recognition and Acute Psycho-Social Stress-induced Cortisol increase in Patients with Central Diabetes lnsipidus (Arginine Vasopressin Deficiency) and Healthy Controls (BASEC)
Titolo accademico
non disponibile
Titolo pubblico
non disponibile
Malattie studiate
non disponibile
Intervento studiato
non disponibile
Tipo di studio
non disponibile
Disegno dello studio
non disponibile
Criteri di inclusione/esclusione
non disponibile
non disponibile
Endpoint primari e secondari
non disponibile
non disponibile
Data di registrazione
non disponibile
Inclusione del primo partecipante
non disponibile
Sponsor secondari
non disponibile
Contatti aggiuntivi
non disponibile
ID secondari
non disponibile
Risultati-Dati individuali dei partecipanti
non disponibile
Ulteriori informazioni sullo studio
non disponibile
Risultati dello studio
Riepilogo dei risultati
non disponibile
Link ai risultati nel registro primario
non disponibile